Search Results1-20 of  45

  • 1 / 3
  • Boku Narikazu ID: 9000264862517

    Articles in CiNii:1

    • Survival prolongation after treatment failure of first-line chemotherapy in patients with advanced gastric cancer : combined analysis of the Japan Clinical Oncology Group Trials JCOG9205 and JCOG9912 (2014)
  • Boku Narikazu ID: 9000264862939

    Articles in CiNii:1

    • HER2-positive gastric cancer (2014)
  • Boku Narikazu ID: 9000329006685

    Articles in CiNii:1

    • Development of an S-1 dosage formula based on renal function by a prospective pharmacokinetic study (2016)
  • Boku Narikazu ID: 9000329006726

    Articles in CiNii:1

    • Excessive watering eyes in gastric cancer patients receiving S-1 chemotherapy (2016)
  • Boku Narikazu ID: 9000329006754

    Articles in CiNii:1

    • Randomized phase Ⅱ study of second-line chemotherapy with the best available 5-fluorouracil regimen versus weekly administration of paclitaxel in far advanced gastric cancer with severe peritoneal metastases refractory to 5-fluorouracil-containing regimens (JCOG0407) (2016)
  • Boku Narikazu ID: 9000361230017

    Articles in CiNii:1

    • Irinotecan monotherapy as third-line treatment for advanced gastric cancer refractory to fluoropyrimidines, platinum, and taxanes (2017)
  • Boku Narikazu ID: 9000368918889

    Articles in CiNii:1

    • Validation of the JCOG prognostic index in advanced gastric cancer using individual patient data from the SPIRITS and G-SOX trials (2017)
  • Boku Narikazu ID: 9000368919703

    Articles in CiNii:1

    • Current management of liver metastases from gastric cancer : what is common practice? New challenge of EORTC and JCOG (2017)
  • Boku Narikazu ID: 9000368922172

    Articles in CiNii:1

    • Clinicopathological features and pathological evaluation of preoperative treatment of patients with resectable esophageal carcinosarcoma (2017)
  • Boku Narikazu ID: 9000380492759

    Articles in CiNii:1

    • Five-weekly S-1 plus cisplatin therapy combined with trastuzumab therapy in HER2-positive gastric cancer : a phase Ⅱ trial and biomarker study (WJOG7212G) (2018)
  • Boku Narikazu ID: 9000380492874

    Articles in CiNii:1

    • A non-randomized confirmatory trial of an expanded indication for endoscopic submucosal dissection for intestinal-type gastric cancer (cT1a) : the Japan Clinical Oncology Group study (JCOG0607) (2018)
  • Boku Narikazu ID: 9000390405157

    Articles in CiNii:1

    • Regional differences in advanced gastric cancer : exploratory analyses of the AVAGAST placebo arm (2018)
  • Boku Narikazu ID: 9000398029929

    Articles in CiNii:1

    • First-line chemotherapy with S-1 alone or S-1 plus cisplatin for elderly patients with advanced gastric cancer : a multicenter propensity score matched study (2018)
  • Boku Narikazu ID: 9000399574832

    Articles in CiNii:1

    • Questionnaire survey on adjuvant chemotherapy for elderly patients after gastrectomy indicates their vulnelabilities (2019)
  • Boku Narikazu ID: 9000399574899

    Articles in CiNii:1

    • Peritoneal metastasis as a predictive factor for nab-paclitaxel in patients with pretreated advanced gastric cancer : an exploratory analysis of the phase Ⅲ ABSOLUTE trial (2019)
  • Boku Narikazu ID: 9000401420845

    Articles in CiNii:1

    • A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2) (2019)
  • Boku Narikazu ID: 9000403259672

    Articles in CiNii:1

    • Association between UGT1A1 gene polymorphism and safety and efficacy of irinotecan monotherapy as the third-line treatment for advanced gastric cancer (2019)
  • Boku Narikazu ID: 9000403921180

    Articles in CiNii:1

    • Randomized study of FOLFIRI plus either panitumumab or bevacizumab for wild-type KRAS colorectal cancer-WJOG 6210G (2016)
  • Boku Narikazu ID: 9000404145917

    Articles in CiNii:1

    • Randomized phase Ⅲ trial of gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer, the short-term safety and surgical results : Japan Clinical Oncology Group Study (JCOG0501) (2019)
  • Boku Narikazu ID: 9000404619792

    Articles in CiNii:1

    • Gastric mucosal injury and hemorrhage after definitive chemoradiotherapy for locally advanced esophageal cancer (2019)
  • 1 / 3
Page Top